RecruitingNot ApplicableNCT05832736

Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate Cancer

Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate Cancer: a Prospective Idea, Development, Exploration, Assessment and Long-term Follow-up (I.D.E.A.L.) Trial

Sponsor

Fondazione del Piemonte per l'Oncologia

Enrollment

36 participants

Start Date

Apr 12, 2023

Study Type

INTERVENTIONAL

Conditions

Prostate Cancer

Summary

On the basis of the now consolidated literature and clinical experience of focal therapies, the execution of partial prostatectomy/hemiprostatectomy with robot-assisted laparoscopic technique can be proposed in a well-selected cohort of patients. The hypothesis is that with this technique it is possible to achieve excellent levels of disease control, in terms of positive surgical margins (PSM) and biochemical recurrence of the disease (BCR), against a minimal impact as regards postoperative functional outcomes (continence and sexual power).

Eligibility

Sex: MALEMin Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating a specialized surgical approach called robotic hemi-prostatectomy — removing only the cancerous half of the prostate while preserving the urethra — for men with low to intermediate risk prostate cancer on only one side of the prostate. The goal is to effectively treat the cancer while better preserving urinary and sexual function. **You may be eligible if...** - You have been diagnosed with low or intermediate risk prostate cancer confirmed on biopsy - The cancer appears to be on only one side of the prostate based on MRI or PET scan - Your PSA (prostate-specific antigen) level is below 20 ng/mL - You have no evidence of cancer spread outside the prostate - Your overall health is good (ECOG 0–1) with a life expectancy of at least 5 years **You may NOT be eligible if...** - Your PSA is above 20 ng/mL - You have had prior prostate surgery - You are unable to have an MRI or PET scan - You are receiving other cancer treatments at the same time Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.